Featured Research

from universities, journals, and other organizations

Using induced pluripotent stem cells, scientists can better study human disease

Date:
April 21, 2013
Source:
Federation of American Societies for Experimental Biology
Summary:
New work has led to major advances in our understanding of embryonic stem cells and "induced pluripotent stem" cells, which appear identical to embryonic stem cells but can be created from adult cells without using an egg.

Rudolf Jaenisch of the Whitehead Institute for Biomedical Research and Massachusetts Institute of Technology will speak at EB 2013 on the topic of stem cells, pluripotency and nuclear reprogramming. His work has led to major advances in our understanding of embryonic stem cells and "induced pluripotent stem" (IPS) cells, which appear identical to embryonic stem cells but can be created from adult cells without using an egg. Dr. Jaenisch will discuss the mechanism of in vitro reprogramming and the inefficiency of gene targeting on April 21 at the meeting of the American Association of Anatomists at Experimental Biology.

Related Articles


The stem cell field is no stranger to controversy and has become widely discussed for the cells' ability to generate any cell type. They offer a new way to study human development. "The greatest interest in using stem cells is for disease research," said Jaenisch. "In the late 1990s when Dolly was cloned, it was called therapeutic cloning. It is considered controversial for using human eggs and is technically difficult. With IPS cells, we now have a way to study the pathogenesis of disease in petri dishes, without human eggs."

According to Jaenisch, where Dolly was a theoretical solution, we now have new technology that makes it possible to move into application. IPS cells will allow scientists to study complex human diseases in Petri dishes, a step toward analyzing the conditions and developing therapies.

Another potential benefit from IPS cells is to use them for transplantation into a patient to cure disease possibly. "We can likely find a way to reduce the risk of organ/tissue rejection. We can also correct mutations in IPS cells," he added, which gives researchers one less complicating factor.


Story Source:

The above story is based on materials provided by Federation of American Societies for Experimental Biology. Note: Materials may be edited for content and length.


Cite This Page:

Federation of American Societies for Experimental Biology. "Using induced pluripotent stem cells, scientists can better study human disease." ScienceDaily. ScienceDaily, 21 April 2013. <www.sciencedaily.com/releases/2013/04/130421153449.htm>.
Federation of American Societies for Experimental Biology. (2013, April 21). Using induced pluripotent stem cells, scientists can better study human disease. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2013/04/130421153449.htm
Federation of American Societies for Experimental Biology. "Using induced pluripotent stem cells, scientists can better study human disease." ScienceDaily. www.sciencedaily.com/releases/2013/04/130421153449.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins